Medtronic plc (MDT) announced that its Diabetes division—set to operate under the name MiniMed—has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) for a proposed initial public offering (IPO) of newly issued common stock.
The planned separation is expected to be executed through a series of capital markets transactions, with the preferred approach being an IPO followed by a subsequent split-off.
MiniMed intends to list its common stock on the Nasdaq Global Select Market under the ticker symbol MMED. The number of shares to be offered and the anticipated price range have not yet been determined. The IPO is expected to launch following the SEC review process, subject to prevailing market conditions and other factors.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.